New CEO Announced for CAMH

TORONTO , Oct. 14 /CNW/ - The CAMH Board of Trustees is extremely pleased to announce that, effective December 1, 2009 , Dr. Catherine Zahn will be the President and CEO of the Centre for Addiction and Mental Health (CAMH), Canada's largest mental health and addiction teaching hospital. Dr. Paul Garfinkel , CAMH's founding President and CEO, will be retiring from the position at that time.

"I am delighted that the CAMH Board has chosen Catherine Zahn as the new leader of the noble enterprise that is CAMH," said Dr. Garfinkel today. "She is an exceptionally skilled, dynamic, experienced leader with a unique capacity for bringing people together in a way that builds respect and promotes consensus. Her passion for helping people with chronic illness to live fully and with dignity epitomizes the values that drive CAMH."

Dr. Zahn , a practicing neurologist, joins CAMH from the University Health Network, where she has served as the Executive Vice President, Clinical Programs and Practice since 2005. A Professor in the Faculty of Medicine at the University of Toronto , she is internationally recognized in the field of neurologic education and has made numerous contributions to health care in Ontario in the areas of technology assessment, chronic disease management and stroke care coordination.

Catherine's reputation in hospital integration, her leadership of the renaissance of the Toronto Western Hospital and a $100M redevelopment project are recent accomplishments in a career that spans more than 25 years and prepares her well to join CAMH.

"CAMH has an ambitious mandate: to help transform the lives of people with mental illness and addictions, through a new model of care and by breaking down stigma. The redevelopment of our 27-acre institutionalized site on Queen Street West into a mixed use urban village reflects our bold agenda," CAMH Board Chair Dan Burns said. "Catherine brings the talent, inclusive values, solid experience and momentum required to lead CAMH in accomplishing its transformational mandate."

Known as a strategic and imaginative leader who is driven to improve clinical care and quality of life for people struggling with illness, she has a track record of recruiting and retaining excellent clinicians. Her support for research as the path to improving care for patients led her to develop the Krembil Neuroscience Centre at the Toronto Western Hospital and extend its reach throughout Ontario and around the world.

" Dr. Garfinkel , the CAMH Board and leadership team have laid the foundation for accelerating change in the world of mental health and addictions," Dr. Zahn said. "I'm energized by the richness of possibility for CAMH and for the people that it serves."

"CAMH is about a spectrum of opportunity, from brain research to city building," she continued. "It's about social change to ensure care and support for people living with mental illness and addictions. It's about the skills and values of a staff who care for our clients. It's about public education and political advocacy. It's about searching for the causes and improving the treatments for mental illness and addictions."

"I'm thrilled by the prospect of working with the talented and committed staff and leadership of CAMH to bring the organization to a new level of distinction."

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in the area of addiction and mental health. CAMH combines clinical care, research, education, policy development, prevention and health promotion to help transform the lives of people affected by mental health and addiction issues.

/NOTE TO PHOTO EDITORS: A photo accompanying this release is available at http://photos.newswire.ca. Images are free to accredited members of the media/

For further information: Media Contact: Michael Torres, CAMH Media Relations; 416-595-6015